Riyad Bank (1010):企業概要・SWOT分析

◆英語タイトル:Riyad Bank (1010) : Company Profile and SWOT Analysis
◆商品コード:SO1902CC
◆発行会社(調査会社):Timetric
◆発行日:2017年1月31日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:サウジアラビア
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site PriceUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprise PriceUSD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTimetric社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
Timetric社の概要はこちらでご確認いただけます。



【レポートの概要】

This report is a crucial resource for industry executives and anyone looking to access key information about “Riyad Bank”
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.


• Examines and identifies key information and issues about "Riyad Bank" for business intelligence requirements.

• Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.

• Provides data on company financial performance and competitive benchmarking.

• The profile also contains information on business operations, company history, major products and services, key employees, and locations and subsidiaries.

【レポートの目次】

1 Riyad Bank – Business Analysis
1.1 Riyad Bank – Company Overview
1.2 Riyad Bank – Business Description
1.3 Riyad Bank – Major Products and Services
2 Riyad Bank – Analysis of Key Performance Indicators
2.1 Riyad Bank – Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Riyad Bank – Key Financial Performance Indicators
2.2.1 Riyad Bank – Total Income and Net Profit Margin
2.2.2 Riyad Bank – Asset and Liabilities
2.2.3 Riyad Bank – Gearing Ratio
2.2.4 Riyad Bank – Valuation
2.3 Riyad Bank – Competitive Benchmarking
2.3.1 Riyad Bank – Market Capitalization
2.3.2 Riyad Bank – Efficiency
2.3.3 Riyad Bank – Valuation
3 Riyad Bank – Mergers & Acquisitions and Partnerships
3.1 Riyad Bank – M&A and Partnerships Strategy
4 Riyad Bank – Recent Developments
5 Riyad Bank – SWOT Analysis
5.1 Riyad Bank – SWOT Analysis – Overview
5.2 Riyad Bank – Strengths
5.3 Riyad Bank – Weaknesses
5.4 Riyad Bank – Opportunities
5.5 Riyad Bank – Threats
6 Riyad Bank – Company Statement
7 Riyad Bank – History
8 Riyad Bank – Key Employees
9 Riyad Bank – Locations and Subsidiaries
9.1 Riyad Bank – Head Office
9.2 Riyad Bank – Other Locations and Subsidiaries
10 Appendix
10.1 Methodology
10.2 Ratio Definitions
10.3 Disclaimer

Table 1: Riyad Bank - Major Products and Services
Table 2: Riyad Bank - Key Ratios - Annual
Table 3: Riyad Bank - Key Ratios - Interim
Table 4: Riyad Bank - Key Capital Market Indicators
Table 5: Riyad Bank - History
Table 6: Riyad Bank - Key Employees
Table 7: Riyad Bank - Subsidiaries


Figure 1: Riyad Bank - Total Income and Net Profit
Figure 2: Riyad Bank - Financial Position
Figure 3: Riyad Bank - Gearing Ratio
Figure 4: Riyad Bank - Valuation
Figure 5: Riyad Bank - Market Capitalization
Figure 6: Riyad Bank - Efficiency
Figure 7: Riyad Bank - Valuation


★海外企業調査レポート[Riyad Bank (1010):企業概要・SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ReShape Lifesciences Inc (RSLS)-医療機器分野:企業M&A・提携分析
    Summary ReShape Lifesciences Inc(ReShape Lifesciences) formerly known as EnteroMedics Inc, is a medical equipment provider that offers therapeutic and neuroregulator systems. The company designs and develops medical devices for the treatment of obesity and other disorders. It develops VBLOC therapy …
  • Caracal Energy Inc.(石油・ガス分野):企業M&A動向
    Summary Caracal Energy Inc. (Caracal Energy), formerly Griffiths Energy International Inc., is an oil and gas exploration and development company. It focuses on the exploration and development of oil and gas reserves and resources in the Republic of Chad. Currently, the company holds three productio …
  • Hydro-Quebec:企業のM&A・提携動向(発電分野)
    Summary Hydro-Quebec is a government-owned energy utility that generates, transmits and distributes electricity. The company specializes in renewable energy generation, using hydro sources and supports the development of electricity using other technologies such as wind energy and biomass. It genera …
  • Schneider Electric SE (SU):企業財務及び戦略的SWOT分析
    Schneider Electric SE (SU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Empyrean Energy PLC (EME)(石油・ガス分野):企業M&A動向
    Summary Empyrean Energy PLC (Empyrean Energy) is an oil and gas company. The company explores, develops and produces energy resource projects. Its projects include Sugarloaf project, Riverbend project in Texas; and Eagle Oil Pool Development, California. The company has interest in Kennedy IH Well a …
  • Centric Holdings S.A (CENTR):企業概要、財務及び戦略的SWOT分析
    Summary Centric Holdings S.A (Centric Holdings) is a technology service provider. The company manages and promotes online entertainment services. It offers video games, educational games, language learning software, and hardware and accessories. Centric Holdings provides and promotes online gaming p …
  • PIQUR Therapeutics AG-製薬・医療分野:企業M&A・提携分析
    Summary PIQUR Therapeutics AG (PIQUR) is a clinical-stage pharmaceutical company that discovers and develops anti-cancer drugs. The company develops innovative small molecule therapeutics based on lipid kinase (PI3K) and mTOR inhibitior for the treatment of cancer and inflammatory diseases. Its pipe …
  • Total E&P USA, Inc.:企業のM&A・提携動向(石油・ガス分野)
    Summary Total E&P USA, Inc. (TEP USA), a subsidiary of Total S.A. is an energy service providing company that explores and produces crude oil and natural gas. The company includes offshore oil production and exploration in the Gulf of Mexico to onshore unconventional shale gas development. It also f …
  • CH Offshore Ltd. (C13):企業概要、財務及び戦略的SWOT分析
    Summary CH Offshore Ltd. (CH Offshore) is an offshore service provider. The company provides offshore support services to oil and gas industry. It offers solutions such as offshore construction support; support services to offshore drilling rigs and installations including anchor-handling services, …
  • Bioorganic Research and Services SA (BNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioorganic Research and Services SA (Bionaturis) is a biotechnology company that develops non-prescription products for production animals and pets. The company offers products such as BNT006, BNT007, BNT010, BNT015 and BNT005. It provides non-therapeutic and therapeutic products for poultry …
  • CMC Limited (CMC):企業の財務及び戦略的SWOT分析
    Summary CMC Limited (CMC) is an information technology company that provides designing, development, testing services and solutions for mission critical systems. The company’s products include optus, genisys broker, genisys configurator life, genisys configurator non life, genisys mobile, genisys po …
  • Eiken Chemical Co.,Ltd. (4549):企業概要、財務及び戦略的SWOT分析
    Summary Eiken Chemical Co.,Ltd. (Eiken) is a medical device company. The company manufactures and sells clinical diagnostics and equipments. It offers fully automated fecal occult blood analyzer such as OC-SENSOR DIANA, OC-SENSOR µ and OC-SENSOR io. Eiken’s real time turbidimeter sector offers LA-32 …
  • LSK BioPartners Inc:企業のM&A・提携動向(医療分野)
    Summary LSK BioPartners Inc (LSK BioPartners) doing business as LSK BioPharma is a developer of healthcare products. It is specialized in the development of new technologies for oncology through preclinical and early clinical development. The company has acquired license to develop and market Apatin …
  • PharmaLundensis AB:医療機器:M&Aディール及び事業提携情報
    Summary PharmaLundensis AB (PharmaLundensis) is a pharmaceutical company that develops drugs for lung diseases. The company develops drugs for chronic obstructive pulmonary disease (COPD), chronic bronchitis and influenza-induced lung failure. It also develops EcoFilter, a system that that eliminate …
  • STX Corporation (011810):企業の財務及び戦略的SWOT分析
    Summary STX Corporation (STX) is a trading company that focuses on trading, resource development, ship management, and investment businesses. Its business operates in four main segments namely; energy, industrial commodity trading, machinery and engine trading, shipping and logistics. The company’s …
  • Anheuser-Busch InBev SA/NV:企業の戦略・SWOT・財務分析
    SummaryAnheuser-Busch InBev SA/NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Selecta Biosciences Inc (SELB)-製薬・医療分野:企業M&A・提携分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a clinical-stage biopharmaceutical company which develops immunotherapies and vaccines to prevent and treat disease. The company’s pipeline products include SEL-212, SELA-070, SEL-701, LMB-100 and others. Its synthetic vaccine particle (SVP) t …
  • South China Morning Post Publishers Limited:企業の戦略・SWOT・財務分析
    SummarySouth China Morning Post Publishers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view …
  • Kogeneracja SA (KGN):企業の財務及び戦略的SWOT分析
    Summary Kogeneracja SA (Kogeneracja) a subsidiary of EDF Polska CUW Sp. z o.o is a power generation company that produces and distributes heat and electric power to various customers. The company offers network heat, network heat of the new generation, electric power and network chill. Kogeneracja c …
  • Mirna Therapeutics, Inc.(製薬・医療分野):企業M&A動向
    Summary Mirna Therapeutics, Inc. (Mirna) is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of microRNA therapeutics. Mirna through its microRNA replacement therapy technology, develops products for cancer treatment. Its lead product, MRX34, a first in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆